Dr. Ann H. Radcliffe, MD

Sigmund H. Hsu, MD, is a board-certified and fellowship-trained neurologist with extensive experience in evaluating and treating neurological disorders in cancer patients. He specializes in primary brain tumors, brain and spinal cord metastases, cancer neurology, and the treatment of chemotherapy neurotoxicity. He’s also an assistant professor in the Vivian L. Smith Department of Neurosurgery at McGovern Medical School at UTHealth Houston. Hsu earned his undergraduate and medical degrees from Warren Alpert Medical School of Brown University in Providence, Rhode Island. He completed his medical internship at the Hospital of Saint Raphael in New Haven, Connecticut, where he was awarded medical intern of the year in 1996. After his residency at New York Presbyterian Weill Cornell Medicine in New York, Hsu completed his fellowship training in neuro-oncology at The University of Texas MD Anderson Cancer Center. Before joining UTHealth Houston, Hsu was on the faculty at MD Anderson, where he served as an assistant professor of neuro-oncology and the neurology residency program director. He is a Brain Tumor Network charter member and has volunteered for several years for Run for the Rose, serving as the medical director from 2005 to 2007. Hsu has presented research at several national conferences, and his work has been published in numerous journals and textbooks. His most recent research is focused on novel therapies for recurrent primary CNS lymphoma, recurrent glioblastoma multiforme, and intralumbar injections for cancer therapy. He has several patents granted and pending for his treatments.